Insiders · Profile

Dennis Phillip Andrew

Chief Medical Officer at NovaBridge Biosciences. Filing since 18 Jun 2026. CIK 0002089237

Company
Date
Role
Action
Shares
Amount
Of holding
18 Sep 2026
Chief Medical Officer
Sold at will
8,209
$5.83K
4.5%
18 Jun 2026
Chief Medical Officer
Sold at will
8,494
$5.61K
5.1%
2 decisions on file.